BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1283090)

  • 1. Species specific monoclonal antibodies to Bacteroides fragilis lipopolysaccharide protect mice from severe infection.
    Brake B; Larcher C; Schulz TF; Prodinger W; Dierich MP
    Zentralbl Bakteriol; 1992 Oct; 277(3):320-8. PubMed ID: 1283090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide.
    Linko-Kettunen L; Arstila P; Jalkanen M; Jousimies-Somer H; Lassila O; Lehtonen OP; Weintraub A; Viljanen MK
    J Clin Microbiol; 1984 Sep; 20(3):519-24. PubMed ID: 6386867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the common immunodominant antigenic determinant in the lipopolysaccharide of Bacteroides fragilis by a monoclonal antibody.
    Linko L; Weintraub A; Arstila P; Pelliniemi LJ; Viljanen MK
    Scand J Immunol; 1987 May; 25(5):469-75. PubMed ID: 2438749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Demonstration of a species specific determinant of Bacteroides fragilis lipopolysaccharides using monoclonal antibodies].
    Schulz TF; Brake BA; Sperzel M; Kofler J; Dierich MP
    Wien Klin Wochenschr; 1985 Mar; 97(5):237-9. PubMed ID: 2581371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Bacteroides ovatus in clinical specimens by immunofluorescence with a monoclonal antibody to B. fragilis lipopolysaccharide.
    Viljanen MK; Linko L; Lehtonen OP
    J Clin Microbiol; 1988 Mar; 26(3):448-52. PubMed ID: 3281973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibody response to Bacteroides fragilis in experimental sinusitis.
    Westrin KM; Stierna P; Weintraub A; Palmgren AC; Nord CE
    Infection; 1991; 19(6):435-9. PubMed ID: 1816114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-Bacteroides-antibodies on Escherichia coli and different Bacteroides species in vitro and vivo.
    Rodloff AC; Hilliger F; Friedman H; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):483-91. PubMed ID: 3541458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay for Bacteroides fragilis infections.
    Hoppes WL; Rissing JP; Smith JW; White AC
    J Clin Microbiol; 1980 Aug; 12(2):205-7. PubMed ID: 6164689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.
    Mancuso G; Midiri A; Biondo C; Beninati C; Gambuzza M; Macrì D; Bellantoni A; Weintraub A; Espevik T; Teti G
    Infect Immun; 2005 Sep; 73(9):5620-7. PubMed ID: 16113279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced bacterial dissemination and liver injury in CD14-deficient mice following a chronic abscess-forming peritonitis induced by Bacteroides fragilis.
    Woltmann A; Gangloff SC; Bruch HP; Rietschel ET; Solbach W; Silver J; Goyert SM
    Med Microbiol Immunol; 1999 Mar; 187(3):149-56. PubMed ID: 10206146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response following subcutaneous and intraperitoneal injection of Bacteroides fragilis in rabbits.
    Landay ME
    Eur J Clin Microbiol; 1982 Aug; 1(4):248-51. PubMed ID: 7173187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of opsonins for Bacteroides fragilis in immune sera collected from experimentally infected mice.
    Ellis TM; Barrett JT
    Infect Immun; 1982 Mar; 35(3):929-36. PubMed ID: 7068222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
    Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
    J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cytokine induction by lipopolysaccharide of Bacteroides fragilis with Salmonella typhimurium in mice.
    Jotwani R; Tanaka Y; Watanabe K; Tanaka-Bandoh K; Kato N; Ueno K
    Microbiol Immunol; 1994; 38(9):763-6. PubMed ID: 7854218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune T cells prevent bacteroides fragilis abscesses.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    Curr Surg; 1983; 40(2):123-6. PubMed ID: 6602035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.